Parenteral Drugs (India) reports consolidated net loss of Rs 36.42 crore in the December 2017 quarter
Sales rise 14.48% to Rs 52.97 crore
Net Loss of Parenteral Drugs (India) reported to Rs 36.42 crore in the quarter ended December 2017 as against net loss of Rs 29.45 crore during the previous quarter ended December 2016. Sales rose 14.48% to Rs 52.97 crore in the quarter ended December 2017 as against Rs 46.27 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales52.9746.27 14 OPM %-23.77-10.07 -PBDT-36.57-26.25 -39 PBT-42.58-33.57 -27 NP-36.42-29.45 -24Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 19 2018 | 5:01 PM IST